{"database": "lobbying", "table": "lobbying_activities", "rows": [[1919446, "7300d101-a72c-4156-9525-f4f6a5d96b5b", "Q4", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2016, "fourth_quarter", "PHA", "PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation \nH.R. 3204 - The Drug Quality and Security Act, implementation\nH.R. 6 - 21st Century Cures\nInnovation For Healthier Americans\nH.R. 34 - 21st Century Cures Act\n \n***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee sequester, Innovation", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 80000, null, 0, 0, "2017-01-18T17:14:19-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1919446"], "units": {}, "query_ms": 0.7479749619960785, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}